- After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists, by Will Stone, NPR, May 30, 2021
- An Archaeology of Marijuana, by Stephen Nash, Sapiens, October 16, 2020
- Cannabis as entheogen: survey and interview data on the spiritual use of cannabis, by Petter Grahl Johnstad, Journal of Cannabis Research, September 22, 2020
- New Research Reveals Why Cannabis Helps PTSD Sufferers, by Emily Earlenbaugh, Forbes, September 17, 2020
- Cannabis And Ketamine: Is There A Risk Of Interaction?, by Kate-Madonna Hindes, The Fresh Toast, June 22, 2020
- Psychiatrist Explores Possible Benefits Of Treating PTSD With Ecstasy Or Cannabis, by Terry Gross, NPR, June 22, 2020
- Is Cannabis a Psychedelic Drug?, by Barbara E. Bauer, MS, Psychedelic Science Review, October 31, 2019
- Journal of Cannabis Research
- Institute of Cannabis Research
- Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A., Jr (2010). The Journal of clinical psychiatry, 71(12), 1605–1611.
- Efficacy of ketamine therapy in the treatment of depression. Mandal, S., Sinha, V. K., & Goyal, N. (2019). Indian journal of psychiatry, 61(5), 480–485.
- Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., Charney, D. S., & Mathew, S. J. (2013). The American journal of psychiatry, 170(10), 1134–1142.
- Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives. Shin, C., & Kim, Y. K. (2020). Psychiatry investigation, 17(3), 181–192
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Singh, J. B., Fedgchin, M., Daly, E., Xi, L., Melman, C., De Bruecker, G., Tadic, A., Sienaert, P., Wiegand, F., Manji, H., Drevets, W. C., & Van Nueten, L. (2016). Biological psychiatry, 80(6), 424–431.
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Zheng, W., Zhou, Y. L., Liu, W. J., Wang, C. Y., Zhan, Y. N., Li, H. Q., Chen, L. J., Li, M. D., & Ning, Y. P. (2018). Journal of psychiatric research, 106, 61–68.
